World Drug Safety Congress Europe 2026

Richmond Pharmacology is pleased to join the World Drug Safety Congress Europe 2026 in Amsterdam, The Netherlands, 23-24 September.

As one of Europe’s leading events dedicated to pharmacovigilance, drug safety, risk management, and patient‑centric safety innovation, the World Drug Safety Congress brings together global industry leaders, regulators, technology partners, and research organisations to shape the future of safety science in healthcare.

‍

Representing Richmond Pharmacology:

• Annie Duffy, Head of Data Science & Pharmacovigilance Commercial Strategy
• Amina Ghareeb, Head of Pharmacovigilance

‍

Our Focus at the Congress

• Innovations in pharmacovigilance and safety surveillance

• Risk management and signal detection strategies

• Safety considerations in early‑phase and first‑in‑human studies

• AI, real‑world evidence, and digital tools supporting safety oversight

• Collaborative approaches between industry, regulators, and patient communities

Connect With Us

If you are attending the World Drug Safety Congress Europe 2026 and would like to explore collaboration or development opportunities:

📧 fasteranswers@richmondpharmacology.com

‍

Find out more here: World Drug Safety Congress Europe 2026 | Amsterdam

‍